Alterity Therapeutics Tapped Macnish Niven As CFO, Succeeding Phillip Hains
Portfolio Pulse from Benzinga Newsdesk
Alterity Therapeutics has appointed Abby Macnish Niven as the new CFO, succeeding Phillip Hains. The company is focused on developing treatments for neurodegenerative diseases.
September 30, 2024 | 11:36 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Alterity Therapeutics has appointed Abby Macnish Niven as the new CFO, succeeding Phillip Hains. This leadership change may influence the company's financial strategy and operations.
The appointment of a new CFO can impact a company's financial strategy and operations. However, the immediate effect on stock price is uncertain as it depends on how the new CFO's strategies align with investor expectations.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 80